AbbVie, Teva Settle Opioid Cases With Florida for Almost $330 Million

By PacConAdmin | March 31, 2022

AbbVie’s Allergan subsidiary and Teva Pharmaceuticals have agreed to pay nearly $330 million to settle claims that they played a role in the opioid abuse and overdose crisis in Florida.
Source: Drug Industry Daily

Posted in Drug Industry Daily